Novo Nordisk A/S | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (95)

Latest Posts

About This Stock More About This Stock
LLY Vs NVO: Which One Is Likely To Become A $1T Company First
Article By: The Tokenist
Thursday, February 8, 2024 5:06 AM EST
Tackling growing waistlines is expected to yield much shareholder value.
In this article: LLY, NVO
Read
Bullish Continuation In '24? 3 Market Areas To Watch
Article By: Zacks Investment Research
Wednesday, January 10, 2024 11:00 PM EST
This article discusses 3 market areas that should outperform dramatically over the next 12 months...
In this article: BMY, NVO, NVS, CYTK, IBB, MSFT, NVDA, IWM, META, GOOGL, KRTX
Read
Are These Biotechs Ready To Launch?
Article By: MoneyShow.com
Saturday, December 9, 2023 12:05 AM EST
Biotech stocks are still in the process of repairing the damage from recent months — and recent years. Indeed, as of a month ago, the SPDR Biotech Fund had been dead money for an unbelievable eight and a half years
In this article: LLY, NVO, NBIX, XBI, ITCI
Read
Pivotal Week Coming Up: Big Tech Earnings, Geopolitics, Technicals, Treasury Yield...
Article By: Rod Raynovich
Monday, October 23, 2023 11:35 AM EST
The upcoming quarter GDP is expected to hit 3.7% which has brought the FED dialogue to “higher rates for longer” which might lead us to a recession in 2024. So watch the yield on the 10-year TSY now at 4.924% but needs to stay below the 5% range.
In this article: IBB, AMZN, MSFT, XBI, META, LLY, MRK, NVO, IEF, IHI, ABBV, ABT, BDX, BSX, UNH, FSMEX, PRHSX, SPY, GEHC
Read
Week In Review: China's Biopharmas Announce $2.5 Billion In Deals
Article By: ChinaBio® Today
Saturday, October 21, 2023 1:39 PM EST
KBP Biosciences sold global rights for its hypertension candidate to Novo Nordisk in an agreement worth up to $1.3 billion. Also, EpimAb Bio sold the rights to use its Fabs-In-Tandem Immunoglobulin platform to Almirall in a $210 million agreement.
In this article: SRXXF, BGNE, WXXWY, ASPHF, NVO, LBTSF, TAK
Read

Latest Tweets for $NVO

No tweets yet!

PARTNER HEADLINES